The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Aug 2017 07:00

RNS Number : 8090M
Grupo Clarin S.A.
02 August 2017
 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.

 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes should in block capital letters.

 

1. Name of the issuer

 

GRUPO CLARÍN S.A.

....................................

 

2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii):

 

....................................

 

3. Name of person discharging managerial responsibilities/director

 

ALEJANDRO ALBERTO URRICELQUI (MANAGER)

SEBASTIAN BARDENGO (MANAGER and ALTERNATE DIRECTOR)

 

....................................

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

....................................

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

3 ABOVE

....................................

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

- URRICELQUI - CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE IN THE FORM OF GLOBAL DEPOSITARY SHARES

 

 - BARDENGO - CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE

 

....................................

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

N/A

....................................

 

8. State the nature of the transaction

 

- URRICELQUI - ACQUISITION OF CLASS B COMMON SHARES IN THE FORM OF GLOBAL DEPOSITARY SHARES

 

-BARDENGO - ACQUISITION OF CLASS B COMMON SHARES

 

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

 

ALEJANDRO A. URRICELQUI Number of shares: 31,000 GDSs, representing 2 Class B Common Shares each

 

SEBASTIAN BARDENGO Number of shares: 1,460 Class B Common Shares

....................................

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

ALEJANDRO A. URRICELQUI Percentage: 0.0333% of CLASS B COMMON SHARES

 

 

SEBASTIAN BARDENGO Percentage: 0.0008% of CLASS B COMMON SHARES

....................................

 

11. Number of shares, debentures or financial instruments relating to shares disposed

N/A

....................................

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

....................................

 

 

13. Price per share or value of transaction

 

 

ALEJANDRO A. URRICELQUI 31,000 GDS at US$ 28.38 per GDS

 

SEBASTIAN BARDENGO: 1,460 shares at AR$ 239.12 per share

 

 

14. Date and place of transaction

 

 

ALEJANDRO A. URRICELQUI: 31,000 GDS on 21, 24 and 26 July 2017, LONDON

 

SEBASTIAN BARDENGO: 1,460 SHARES on 20 July 2017, Buenos Aires

....................................

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

ALEJANDRO A. URRICELQUI:

173,158 COMMON SHARES (0.0602% OF OUTSTANDING CAPITAL STOCK)

 

SEBASTIAN BARDENGO:

6,460 COMMON SHARES (0.0022% OF OUTSTANDING CAPITAL STOCK)

 

 

....................................

 

16. Date issuer informed of transaction

 

....................................

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17. Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following notification

....................................

 

23. Any additional information

 

N/A

....................................

 

24. Name of contact and telephone number for queries

 

IN BUENOS AIRES:

AGUSTIN MEDINA MANSON/PATRICIO GENTILE

GRUPO CLARÍN

EMAIL: INVESTORS@GRUPOCLARIN.COM

 

IN LONDON:

ALEX MONEY

JASFORD IR

TEL: +44 20 3289 5300

EMAIL: ALEXM@JASFORD.COM 

 

IN NEW YORK:

MELANIE CARPENTER

I-ADVIZE CORPORATE COMMUNICATIONS

TEL: +1 212 406 3692

EMAIL: CLARIN@I-ADVIZE.COM

....................................

Name and signature of duly authorised officer of issuer responsible for making notification

 

AGUSTIN MEDINA MANSON, Responsible for Market Relations, Grupo Clarín S.A.

....................................

Date of notification

August 1st, 2017

....................................

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSSFMFFWSEFA
Date   Source Headline
2nd Jun 20147:38 amRNSBoard of Directors Receives Note from Shareholder
27th May 20147:57 amRNSExtraordinary Meeting of Shareholders
23rd May 20147:02 amRNSCourt of Appeals Extends Injunction
21st May 201412:59 pmRNSOffer Accepted subject to Shareholder Approval
19th May 20147:00 amRNSDividend Declaration
16th May 20147:25 amRNSBoard receives letters from certain shareholders
14th May 20144:57 pmRNSMinutes of the Meeting of the Board of Directors
12th May 20141:00 pmRNSResults for the First Quarter for 2014 (1Q14)
8th May 20145:03 pmRNSAppointment of Chairman and Vice Chairman
8th May 20142:00 pmRNSConference call and webcast: Q1 2014 Results
6th May 20147:01 amRNSAnnual Ordinary Shareholders' Meeting
2nd May 20145:08 pmRNSConference call and webcast
28th Apr 20143:22 pmRNSMinutes of the Meeting of the Board of Directors
28th Apr 20147:55 amRNSGCSA Responds to Information Request
28th Apr 20147:50 amRNSMinutes of the Meeting of the Audit Committee
28th Apr 20147:45 amRNSMinutes of the Meeting of the Board of Directors
31st Mar 20141:00 pmRNSResult of Meeting
27th Mar 20147:02 amRNSSupplementary Information on ANSES claim
26th Mar 20142:33 pmRNSHector Aranda Leave of Absence
24th Mar 20147:01 amRNSANSES brings claim against Grupo Clarin
24th Mar 20147:00 amRNSExtraordinary Shareholders' Meeting
17th Mar 20147:30 amRNSAnnual Financial Report
14th Mar 20147:02 amRNSSupreme Court Renders Decision
11th Mar 201412:55 pmRNSResults for 4Q13 and FY13
10th Mar 20147:22 amRNSGCSA Responds Shareholder Information Request
3rd Mar 20145:00 pmRNSNotice of Results
3rd Mar 20148:06 amRNSBoard of Directors Meeting Minutes
28th Feb 20143:45 pmRNSSecond Price Monitoring Extn
28th Feb 20143:40 pmRNSPrice Monitoring Extension
19th Feb 20147:02 amRNSBoard of Directors Meeting Minutes
19th Feb 20147:00 amRNSAFSCA Resolution
17th Feb 20143:45 pmRNSSecond Price Monitoring Extn
17th Feb 20143:40 pmRNSPrice Monitoring Extension
13th Feb 20143:26 pmRNSOfficial Publicity - Supreme Court Decision
10th Feb 20143:40 pmRNSPrice Monitoring Extension
29th Jan 20143:41 pmRNSGCSA makes equity contribution in subsidiary
27th Jan 20143:45 pmRNSSecond Price Monitoring Extn
27th Jan 20143:40 pmRNSPrice Monitoring Extension
24th Jan 20143:45 pmRNSSecond Price Monitoring Extn
24th Jan 20143:40 pmRNSPrice Monitoring Extension
10th Jan 20147:00 amRNSLeave of Absence requested
24th Dec 20137:00 amRNSMembers of Company Board request Leaves of Absence
6th Dec 20133:45 pmRNSSecond Price Monitoring Extn
6th Dec 20133:40 pmRNSPrice Monitoring Extension
2nd Dec 20133:45 pmRNSSecond Price Monitoring Extn
2nd Dec 20133:40 pmRNSPrice Monitoring Extension
20th Nov 20132:33 pmRNSARTEAR sells participation in Ideas del Sur S.A.
15th Nov 20132:45 pmRNSARTEAR sells participation in Ideas del Sur S.A.
12th Nov 20131:41 pmRNSRegistration of GC Dominio Effective Again
8th Nov 201312:00 pmRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.